Le Versoud, France

Philippe Roche

USPTO Granted Patents = 21 

 

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 85(Granted Patents)


Location History:

  • Toulouse, FR (1996)
  • Meylan, FR (2003 - 2004)
  • Le Versoud, FR (2007 - 2011)
  • Biviers, FR (2013 - 2021)
  • Marseilles, FR (2021 - 2022)

Company Filing History:


Years Active: 1996-2022

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Philippe Roche: Innovator in Xanthine Derivative Compounds

Introduction

Philippe Roche, an esteemed inventor based in Le Versoud, France, holds an impressive portfolio of 21 patents. His notable contributions to the field of medicinal chemistry, particularly in the development of xanthine derivative compounds, highlight his commitment to advancing pharmaceutical innovations.

Latest Patents

Roche's recent breakthroughs include significant patents related to xanthine derivative inhibitors of BET proteins. These inventions focus on compounds that inhibit BET bromodomains proteins, offering potential new avenues for therapeutic applications. One of his latest patents describes a specific compound characterized by its unique formula. In this formula, various groups such as alkyl, arylene radicals, and sulfonyl groups play critical roles in the compound's function as an inhibitor. These innovations are set to have impactful implications in drug development and treatment options.

Career Highlights

Throughout his career, Philippe Roche has made substantial contributions while working with prominent companies like STMicroelectronics. His role at this leading semiconductor manufacturer allowed him to refine his skills in research and development, driving innovations in technology and medicine.

Collaborations

Roche has worked alongside notable colleagues such as Sylvain Clerc and François Jacquet. Their collaborations have fostered an environment of shared knowledge and ingenuity, contributing to the successful patenting of various innovative compounds.

Conclusion

Philippe Roche's work in the realm of xanthine derivatives represents a significant advancement in the field of pharmaceuticals. His dedication to innovation and collaboration with industry leaders positions him as a key figure in the ongoing development of effective medicinal compounds. With 21 patents to his name, Roche continues to influence the landscape of drug discovery and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…